Legislative Activity

The Restoring Essential Healthcare Act repeals an outdated ban that prevented Medicaid from making payments to certain healthcare providers. This legislation ensures that these previously prohibited entities will now be reimbursed for medical services rendered between the enactment of the original ban and the passage of this Act. In short, it restores payment eligibility and retroactively covers past services.

The EATS Act of 2025 significantly updates eligibility for the Supplemental Nutrition Assistance Program (SNAP) by removing previous restrictions that often disqualified students. This legislation explicitly includes bona fide students enrolled at least half-time in recognized educational programs as eligible participants for food assistance. These changes take effect on January 2, 2026.

The Keep Kids Covered Act aims to ensure children maintain continuous health coverage under Medicaid and CHIP for longer periods. This legislation extends continuous eligibility for children under age 19, significantly increasing the duration they remain covered without needing to re-enroll. Furthermore, it grants former foster youth continuous Medicaid eligibility until they turn 26.

The Resident Physician Shortage Reduction Act of 2025 establishes a structured process for distributing up to 2,000 additional, federally funded residency positions annually between fiscal years 2026 and 2032. This distribution prioritizes hospitals serving in underserved areas, those already training above their limit, and those committed to primary care and general surgery training. The bill also mandates a study and report by the Comptroller General on effective strategies to increase diversity within the health professional workforce.

This proposed constitutional amendment would eliminate immunity from criminal prosecution for federal officials, including the President, based on their official duties. It also explicitly prohibits the President from issuing a self-pardon for any federal crimes. If ratified, these changes would take effect immediately.

The EACH Act of 2025 aims to ensure equal access to abortion coverage by requiring all federally funded health programs and facilities to cover abortion services. This legislation prohibits federal interference with state or private insurance coverage of abortion and repeals Section 1303 of the Affordable Care Act. Ultimately, the bill seeks to eliminate financial and insurance barriers to abortion care, particularly for low-income individuals relying on programs like Medicaid.

The 340B PATIENTS Act of 2025 clarifies and strengthens the existing 340B drug discount program for covered entities like hospitals and clinics. It explicitly prohibits drug manufacturers from placing restrictions on how or where these entities purchase or dispense discounted outpatient drugs, including through contract pharmacies. The bill also establishes significant civil monetary penalties for manufacturers who intentionally violate these non-restriction rules. Ultimately, this legislation aims to ensure that covered entities can fully utilize 340B savings to expand patient care.

The Ally's Act mandates that certain private health insurance plans must cover auditory implant devices, related supplies, and necessary services for qualifying individuals. This coverage must be comparable to other medical and surgical benefits regarding cost-sharing and treatment limitations. Furthermore, plans cannot deny coverage if a physician or qualified audiologist determines the required hearing items or services are medically necessary. These new requirements take effect for plan years beginning on or after January 1, 2026.

This bill amends the Family and Medical Leave Act (FMLA) to explicitly clarify that time taken off for an employee's own organ donation surgery qualifies as a serious health condition. This ensures both private and federal sector workers receive FMLA protection for recovery from organ donation. The legislation also specifies how federal employees must substitute existing paid leave when taking FMLA time for this purpose.

The Living Donor Protection Act of 2025 prohibits life, disability, and long-term care insurance companies from denying coverage or increasing premiums solely because an individual is a living organ donor. This legislation ensures that living donors are not financially penalized for their altruistic act. Additionally, the bill requires the Secretary of HHS to update educational materials to accurately reflect the insurance protections afforded to living donors.

The Medicare Breast Reconstruction Access and Information Act mandates that suppliers performing medically necessary mastectomies must inform patients about their Medicare coverage for post-mastectomy breast reconstruction. This information must be provided and documented in the patient's medical file before the surgery takes place. Failure to comply will result in Medicare withholding payment for the mastectomy procedure.

The Medicaid Breast Cancer Access to Treatment Act expands Medicaid eligibility to cover certain individuals who have had breast or cervical cancer. This legislation also mandates that Medicaid coverage must include breast reconstruction surgery following a medically necessary mastectomy. These changes aim to ensure comprehensive care and remove financial barriers for cancer survivors under the program.

The Right to FDA-Approved Medicines Act guarantees individuals the right to obtain and receive information about medicines already approved by the FDA. This law preempts and overrides conflicting federal and state regulations that restrict access to or the provision of these approved drugs by healthcare providers. It establishes strong enforcement mechanisms, allowing both the Attorney General and private citizens to sue states that violate these protections.

This resolution declares a health and safety emergency disproportionately affecting children due to prior administration directives that promoted fossil fuels and suppressed climate science. Congress asserts that these actions harm children's fundamental rights to life and a stable environment by worsening climate change impacts. The bill demands the current administration cease policies that increase greenhouse gases and restore access to suppressed climate research. Ultimately, it calls for aligning all energy and climate laws with the duty to protect the rights and future of young people.

This bill reauthorizes the Public Health and Bio-Preparedness Workforce Loan Repayment Program through fiscal year 2030. It ensures continued support for professionals working in public health and bio-preparedness by extending their eligibility for loan repayment. This action secures the program for five additional years.

The Uterine Cancer Study Act of 2025 mandates a comprehensive federal study to investigate the potential link between the use of chemical hair straighteners and the risk of developing uterine cancer. This research must specifically examine disparities in cancer rates among women of color. The study will ultimately recommend whether the FDA should require additional safety testing for these hair products.

The DIGNIDAD Act of 2025 is a comprehensive bill that significantly overhauls U.S. immigration policy across five major divisions. Division A focuses on aggressive border security enhancements, infrastructure modernization, and increased criminal penalties for immigration offenses, while Division B establishes pathways to legal status for long-term residents who entered as children and creates a temporary protection program for others. Finally, Division C aims to improve legal immigration by reducing green card backlogs, streamlining employment and student visas, and providing new discretionary relief for family separation cases.

The Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 aims to improve the detection and treatment of uterine fibroids. It mandates federal research to develop evidence-based early detection strategies and establishes grant programs for states to fund screening, education, and intervention services, prioritizing vulnerable populations. Furthermore, the bill allocates funding for research into pain management related to fibroid surgery and other uterine conditions.

The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025 aims to significantly increase federal research, public education, and provider awareness regarding uterine fibroids. The bill mandates expanded research coordination across federal agencies and authorizes funding to study the condition, which disproportionately affects minority women. It also requires the creation of public awareness campaigns detailing non-hysterectomy treatment options and mandates data collection on Medicaid/CHIP spending for fibroid treatments.

This Act establishes the **Consumer Safety Technology Act** to explore the use of emerging technologies in consumer protection. It mandates the CPSC to launch a pilot program using **Artificial Intelligence (AI)** to enhance product safety monitoring. Furthermore, the law directs studies on the potential of **Blockchain Technology** for fraud prevention and requires the FTC to report on unfair practices involving **digital tokens**.